Carl Icahn: We Won’t Sell Biogen Immediately
1 CommentBy Ed Silverman // May 28th, 2008 // 7:48 am
| S | M | T | W | T | F | S |
|---|---|---|---|---|---|---|
| « Apr | Jun » | |||||
| 1 | 2 | 3 | ||||
| 4 | 5 | 6 | 7 | 8 | 9 | 10 |
| 11 | 12 | 13 | 14 | 15 | 16 | 17 |
| 18 | 19 | 20 | 21 | 22 | 23 | 24 |
| 25 | 26 | 27 | 28 | 29 | 30 | 31 |
• Pharma Blog » 2008
Pharmalot May, 2008 Archive
FDA’s Woodcock: Safety Is Slowing Things Down
3 CommentsBy Ed Silverman // May 27th, 2008 // 5:09 pm
Express Scripts To Pay $9.5M For Drug Switching
Make a commentBy Ed Silverman // May 27th, 2008 // 5:02 pm
Whytorin? Schering-Plough Boosts Investor Effort
Make a commentBy Ed Silverman // May 27th, 2008 // 4:47 pm
Johnson & Johnson’s ‘Me-Too’ Schizophrenia Drug
Make a commentBy Ed Silverman // May 27th, 2008 // 2:43 pm
J&J Devices, Sales Reps And The Gray Market
Make a commentBy Ed Silverman // May 27th, 2008 // 11:48 am
Kiss And Make It Better? A Placebo Pill For Kids
25 CommentsBy Ed Silverman // May 27th, 2008 // 8:19 am
Vermont Irked By Revised Senate Disclosure Bill
1 CommentBy Ed Silverman // May 27th, 2008 // 7:32 am